Vapers have been eagerly awaiting the FDA’s regulatory action on electronic cigarettes. It appears however that they will need to wait slightly longer. News broke this week that FDA was sponsoring a fresh study at the Center for Tobacco Research and Investigation under the auspices of University of Wisconsin. This will examine long-term impact of electronic cigarettes on health.
The study aims at tracking participants for a five-year period and will cost 3.7 million dollars. FDA in conjunction with National Cancer Institute of National Institutes of Health provided grants for covering the research. FDA is offering investment for the study, raising suspicion that regulations for e-cigs will remain active slightly longer as regulators establish the real benefits vis-à-vis risks of vaping.
University of Wisconsin’s director of Clinical Services, Dr. Doug Jorenby, indicated that research is now of greatest importance for the e-cigarette industry. He stated that beginning 1950s, cigarettes had been studied intensively within the US and electronic cigarettes had just below a decade of existence within the market. Dr. Jorenby expressed concern that there was little scientific evidence to demonstrate the positive and negative effects of using electronic cigarettes, except knowing that they had gained immense popularity.
The choice of vaping is getting more common among individuals keen to quit smoking. However, providers of health care still treat the practice with great suspicion. FDA has not maintained solid position about regulation of e-cigarettes. Jorenby commented that they lacked the hard numbers necessary for influencing policy decisions, alluding that research required some lag time before obtaining the relevant information, which they were working very hard to attain.
Researchers will during the new study, follow a total of 400 participants, comprising of 150 regular cigarette smokers along with 250 smokers who also use e-cigarettes. Jorenby stated they would follow them over a number of years and investigate all types of health effects, including exposure to certain potential cancer-risk biomarkers. He indicated that they would be focusing at their pulmonary as well as lung function.
Regulators have hope that this new study will offer vital information to assist them in deciding about how to formulate safe vaping industry rules. Do you suppose that FDA will suspend the regulations till the study of five years is completed?